Early-Stage Patient Safety Innovation of the Year

PSA
Early-Stage Patient Safety Innovation of the Year
Read more

Accelerating innovation will be crucial to the future of the health service, and there is never a shortage of good ideas. This award celebrates products or innovations which are in the early stages of their development and will look to drive consistent improvements in patient safety. Judges are looking for new, game changing concepts which improve safety in one or multiple spheres of care. This can be anything from the development of a technology, system or process, training programme, patient led initiative, or a combination of these to solve a particularly challenging problem.

This award celebrates innovations that cannot yet supply reams of clinical evidence but show true promise in delivering demonstrable and positive consequences for patient safety both in their current setting and elsewhere. Though not necessarily supported by long-term evidence from the field the potential for reductions in harm, changes in process or treatment resulting in better safer care must be intrinsic the to design and application of the innovation.

Eligibility

Entries are welcomed from all parts of the NHS and public sector including academic institutions that can demonstrate the obvious potential for improvements in the safe care of patients. Judges are interested in ideas that can demonstrate results from the last two years.

Ambition

  • Describe the context of the innovation – why and how did the idea come about?
  • Explain the targets and goals that were set, including how the innovation can help make tangible improvements to the safe care of patients, or which reduce harm.
  • Discuss what measures were employed to achieve these targets.

Outcome

  • Although initial results may be limited, in as much detail as possible provide evidence of success in the testing and initial implementation of the innovation.
  • How are these results to be sustained and/or improved upon moving forward?
  • Provide quantitative and qualitative supporting material, including patient and staff feedback.
  • Judges will be looking for evidence which clearly shows the potential of this innovation to improve safety.

Spread

  • How, and to what extent, has the success of the innovation been communicated and shared elsewhere with the organisation or system?
  • How have or will patient safety leads be involved in the wider roll-out of this innovation?
  • Judges are looking for potential of application across other departments and in the wider health sector in the future.

Value

  • Describe the value created by the innovation so far.
  • Detail any ways in which the innovation benefited patients or staff outside of the original expectations.
  • Judges will be looking for projects which not only have the capacity to reduce harm but can also provide a financial value or return.
  • Considering the potential of the project, what and where might value be achieved in the future?

Involvement

  • Provide clear evidence surrounding the measures taken to inform, involve and enable participation from end-users and patients in the design of the innovation.
  • Describe how staff, patients and other stakeholders across the organisation were engaged in the implementation of the innovation.
  • Share how feedback has been captured from these groups over time, and what enhancements this has delivered.

To find out more

Partnership opportunities:  Natasha Dwyer, Head of Sponsorship Sales
Awards entry enquiries: Frank Willing, Delegate Sales Manager